Results 121 to 130 of about 21,933 (136)

Solubility measurement of a chemotherapeutic agent (Imatinib mesylate) in supercritical carbon dioxide: Assessment of new empirical model

Journal of Supercritical Fluids, 2019
Gholamhossein Sodeifian, Seyed Ali Sajadian, Fariba Razmimanesh   +2 more
exaly  

Imatinib Mesylate

2006
openaire   +1 more source

Evaluation of Imatinib Mesylate in the Treatment of Pulmonary Arterial Hypertension

Future Cardiology, 2010
Shambhu Aryal
exaly  

Antitumor activity of imatinib mesylate in neuroblastoma xenografts

Cancer Letters, 2005
Marco Gessi, Tiziana Servidei
exaly  

Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Prostate Cancer

Annals of Pharmacotherapy, 2005
Joshua Samuels, Kevin W Finkel
exaly  

Identification of Differentially Expressed Proteins in Imatinib Mesylate-resistant Chronic Myelogenous Cells

BMB Reports, 2005
Youngsoo Kim, Sung-Soo Yoon, Jungeun Park   +2 more
exaly  

Imatinib mesylate in the treatment of chronic myeloid leukaemia

Expert Opinion on Pharmacotherapy, 2003
Brian Druker
exaly  

Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)

Journal of Bone and Mineral Metabolism, 2006
Hideki Tsuboi, Wataru Ando, Akihide Nampei   +2 more
exaly  

Another Look at Imatinib Mesylate

New England Journal of Medicine, 2007
Schellings, Mark W., Löwenberg, Bob, Pinto, Yigal M.   +2 more
openaire   +3 more sources

Imatinib mesylate in the treatment of systemic mastocytosis

Cancer, 2006
exaly